These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 7768283
1. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro. Allen MJ, Coleman RA. Eur J Pharmacol; 1995 Feb 14; 274(1-3):7-15. PubMed ID: 7768283 [Abstract] [Full Text] [Related]
2. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Tomlinson PR, Wilson JW, Stewart AG. Br J Pharmacol; 1994 Feb 14; 111(2):641-7. PubMed ID: 7911722 [Abstract] [Full Text] [Related]
4. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue. Cook SJ, Small RC, Berry JL, Chiu P, Downing SJ, Foster RW. Br J Pharmacol; 1993 Aug 14; 109(4):1140-8. PubMed ID: 8104643 [Abstract] [Full Text] [Related]
5. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses. Martin SW, Broadley KJ. Br J Pharmacol; 1994 Jun 14; 112(2):595-603. PubMed ID: 7915614 [Abstract] [Full Text] [Related]
8. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Chong LK, Cooper E, Vardey CJ, Peachell PT. Br J Pharmacol; 1998 Mar 14; 123(5):1009-15. PubMed ID: 9535032 [Abstract] [Full Text] [Related]
10. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. Haynes JM. Eur J Pharmacol; 2007 Sep 10; 570(1-3):18-26. PubMed ID: 17617401 [Abstract] [Full Text] [Related]
11. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells. Carter AA, Hill SJ. J Pharmacol Exp Ther; 2005 Nov 10; 315(2):839-48. PubMed ID: 16051698 [Abstract] [Full Text] [Related]
12. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells. Wang XS, Lau HY. Clin Exp Pharmacol Physiol; 2006 Aug 10; 33(8):746-50. PubMed ID: 16895550 [Abstract] [Full Text] [Related]
13. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat. Bahl AK, Clayton NM, Coates J, Martin DP, Oakley IG, Strong P, Trevethick MA. Br J Pharmacol; 1996 Feb 10; 117(3):580-586. PubMed ID: 8821552 [Abstract] [Full Text] [Related]
15. Contractile and relaxant properties of rat-isolated pulmonary veins related to localization and histology. Bronquard C, Maupoil V, Arbeille B, Fetissof F, Findlay I, Cosnay P, Freslon JL. Fundam Clin Pharmacol; 2007 Feb 10; 21(1):55-65. PubMed ID: 17227445 [Abstract] [Full Text] [Related]
16. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo. Takeda H, Igawa Y, Komatsu Y, Yamazaki Y, Akahane M, Nishizawa O, Ajisawa Y. Eur J Pharmacol; 2000 Sep 01; 403(1-2):147-55. PubMed ID: 10969156 [Abstract] [Full Text] [Related]
17. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Nials AT, Sumner MJ, Johnson M, Coleman RA. Br J Pharmacol; 1993 Feb 01; 108(2):507-15. PubMed ID: 8095419 [Abstract] [Full Text] [Related]